Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID: FERMENTA
  • BSEID: 506414
INR
318.45
-3.25 (-1.01%)
BSENSE

Jun 18

BSE+NSE Vol: 49.76 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kopran
Wanbury
Lincoln Pharma.
Syncom Formul.
Bajaj Healthcare
Themis Medicare
Shukra Pharma.
Bharat Parenter.
Fermenta Biotec.
Accent Microcell
Remus Pharma.
Why is Fermenta Biotech Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.88%
  • Poor long term growth as Net Sales has grown by an annual rate of 6.85% and Operating profit at 4.95% over the last 5 years
2
With a fall in Net Sales of -13.06%, the company declared Very Negative results in Mar 26
  • The company has declared negative results for the last 2 consecutive quarters
  • The company has declared negative results in Dec 25 after 5 consecutive negative quarters
  • PBDIT(Q) Lowest at Rs 20.00 cr.
  • OPERATING PROFIT TO NET SALES(Q) Lowest at 16.45%
  • PBT LESS OI(Q) Lowest at Rs 12.08 cr.
3
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Sideways on 15-Jun-26 and has generated -2.08% returns since then
  • A key technical factor - KST has been Bearish since 15 Jun 2026
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fermenta Biotec. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Fermenta Biotec.
-2.81%
-0.03
51.82%
Sensex
-4.95%
-0.37
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.85%
EBIT Growth (5y)
4.95%
EBIT to Interest (avg)
2.91
Debt to EBITDA (avg)
6.43
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
0.80
Tax Ratio
26.72%
Dividend Payout Ratio
9.49%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
8.03%
ROE (avg)
8.36%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
34
Price to Book Value
2.33
EV to EBIT
13.04
EV to EBITDA
10.21
EV to Capital Employed
2.13
EV to Sales
1.94
PEG Ratio
NA
Dividend Yield
0.78%
ROCE (Latest)
16.34%
ROE (Latest)
16.45%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DEBT-EQUITY RATIO(HY)

Lowest at 0.28 times

-23What is not working for the Company
PBDIT(Q)

Lowest at Rs 20.00 cr.

OPERATING PROFIT TO NET SALES(Q)

Lowest at 16.45%

PBT LESS OI(Q)

Lowest at Rs 12.08 cr.

PAT(Q)

Lowest at Rs 12.75 cr.

NET SALES(Q)

Lowest at Rs 121.58 cr

Loading Valuation Snapshot...
Here's what is working for Fermenta Biotec.
Debt-Equity Ratio - Half Yearly
Lowest at 0.28 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Fermenta Biotec.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 12.08 cr has Fallen at -57.00%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 12.75 cr has Fallen at -62.9%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 121.58 cr has Fallen at -13.06%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 20.00 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 16.45% and Fallen
each quarter in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 12.08 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Lowest at Rs 12.75 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 121.58 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)